ENSURE-AF trial supports edoxaban for electrical cardioversion
ROME – Results of the largest-ever randomized clinical trial of anticoagulation for electrical cardioversion of patients with nonvalvular atrial fibrillation demonstrate that edoxaban is a safe,...
Source: Hospitalist News - Category: Hospital Management Source Type: research
More News: Atrial Fibrillation | Cardiology | Clinical Trials | Heart | Hospital Management | Hospitalists